平特五不中

Home

Jean-Fran莽ois Boileau

Academic title(s): 

Associate Professor Surgery and Gerald Bronfman Oncology, 平特五不中

Location: 
Jewish General Hospital
Office: 
E-710
Division: 
General Surgery
Hospital title: 
Director of the Jewish General Hospital Breast Clinical Trials Group
Founding member of the Quebec McPeak-Sirois clinical trials consortium
Degree(s): 

MD, MS, FRCSC

Awards, honours, and fellowships: 
  • 2007 Royal College of Physicians and Surgeons of Canada/ Society of Surgical Oncology/ Canadian Society of Surgical Oncology Fellowship in General Surgical Oncology.
  • 2015 Harvey Sigman Teaching Award. Undergraduate Teaching 平特五不中.
  • 2019 Prix Banque Nationale Innovation et Soutien 脿 la Communaut茅 de la Fondation du Cancer du Sein du Qu茅bec
Current research: 

Senior investigator. 鈥淭argeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer, the TADEN study鈥� (Funded by the Quebec Breast Cancer Foundation)

- PI: Leamarie Meloche-Dumas, Co-Senior Author: Erica Patocskai

- ClinicalTrials.gov Identifier: NCT04671511:

听

List of ongoing breast clinical trials at the JGH:

Clinical Interests: 

Breast Cancer

Language(s) spoken: 
English
French
Biography: 

Dr. Boileau is associate professor in the Department of Surgery and associate member of the Gerald Bronfman Department of Oncology at 平特五不中. He is a surgical oncologist and clinician scientist at the Montreal Jewish General Segal Cancer Centre. He is currently the head of the Jewish General Hospital鈥檚 Breast Clinical Trial鈥檚 Group and a founding member of the Quebec McPeak-Sirois Clinical Trials Consortium.


Dr. Boileau is the Principle Investigator of the SN FNAC study that has helped to establish sentinel node biopsy as an acceptable method to re-stage the axilla of node positive breast cancer patients after neoadjuvant therapy (Published in the Journal of Clinical Oncology).

Selected publications: 
  • Wong SM, Boileau JF. Ann Surg Oncol. 2020 Oct 29. doi: 10.1245/s10434-020-09259-y . Online ahead of print.PMID: 33123855
  • Wong SM, Basik M, Florianova L, Margolese R, Dumitra S, Muanza T, Carbonneau A, Ferrario C,Boileau JF. Ann Surg Oncol. 2020 Oct 23. doi: 10.1245/s10434-020-09211-0. Online ahead of print.PMID: 33095362
  • Parvez E, Martel K, Morency D, Dumitra S, Meguerditchian AN, Dionisopoulos T, Meterissian S, Basik M, Boileau JF. Clin Breast Cancer. 2020 Aug;20(4):353-358. doi: 10.1016/j.clbc.2020.03.001. Epub 2020 Mar 8.PMID: 32305298
  • Safran T, Al-Halabi B, Viezel-Mathieu A, Boileau JF, Dionisopoulos T. Plast Reconstr Surg. 2020 Jan 7.
  • Fehrenbacher L, Cecchini RS, Geyer CE Jr, Rastogi P, Costantino JP, Atkins JN, Crown JP, Polikoff J, Boileau JF, Provencher L, Stokoe C, Moore TD, Robidoux A, Flynn PJ, Borges VF, Albain KS, Swain SM, Paik S, Mamounas EP, Wolmark N. J Clin Oncol. 2020 Feb 10;38(5):444-453.
  • Viezel-Mathieu A, Alnaif N, Aljerian A, Safran T, Brabant G, Boileau JF, Dionisopoulos T. Ann Plast Surg. 2020 Feb;84(2):139-143.
  • Morency D, Dumitra S, Parvez E, Martel K, Basik M, Robidoux A, Poirier B, Holloway CMB, Gaboury L, Sideris L, Meterissian S, Boileau JF. Ann Surg Oncol. 2019 Dec;26(13):4337-4345. doi: 10.1245/s10434-019-07809-7. Epub 2019 Oct 11.
  • Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, Wildiers H, Campone M, Boileau JF, Fasching PA, Afenjar K, Spera G, Lopez-Valverde V, Song C, Trask P, Boulet T, Sparano JA, Symmans WF, Thompson AM, Slamon D. J Clin Oncol. 2019 Sep 1;37(25):2206-2216. doi: 10.1200/JCO.19.00882. Epub 2019 Jun 3.
  • Johnston S, Puhalla S, Wheatley D, Ring A, Barry P, Holcombe C, Boileau JF, Provencher L, Robidoux A, Rimawi M, McIntosh SA, Shalaby I, Stein RC, Thirlwell M, Dolling D, Morden J, Snowdon C, Perry S, Cornman C, Batten LM, Jeffs LK, Dodson A, Martins V, Modi A, Osborne CK, Pogue-Geile KL, Cheang MCU, Wolmark N, Julian TB, Fisher K, MacKenzie M, Wilcox M, Huang Bartlett C, Koehler M, Dowsett M, Bliss JM, Jacobs SA. J Clin Oncol. 2019 Jan 20;37(3):178-189.
  • Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang CS, Thompson AM, Harbeck N, Valero V, Stroyakovskiy D, Wildiers H, Campone M, Boileau JF, Beckmann MW, Afenjar K, Fresco R, Helms HJ, Xu J, Lin YG, Sparano J, Slamon D. Lancet Oncol. 2018 Jan;19(1):115-126.
  • Wong SM, King T, Boileau JF, Barry WT, Golshan M. Ann Surg Oncol. 2017 Sep;24(9):2509-2517.
  • Broglio KR, Quintana M, Foster M, Olinger M, McGlothlin A, Berry SM, Boileau JF, Brezden-Masley C, Chia S, Dent S, Gelmon K, Paterson A, Rayson D, Berry DA. JAMA Oncol. 2016 Jun 1;2(6):751-60.
  • Simmons CE, Hogeveen S, Leonard R, Rajmohan Y, Han D, Wong A, Lee J, Brackstone M, Boileau JF, Dinniwell R, Gandhi S. . Curr Oncol. 2015 March; 22(Suppl 1): S43鈥揝53.
  • Boileau JF, Poirier B, Basik M, Holloway C, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp S, Wright F, Younan R, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Sentinel Node biopsy Following NeoAdjuvant Chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study. J Clin Oncol. 2015 Jan 20;33(3):258-64.
  • Verma S, Joy AA, Rayson D, McLeod D, Brezden-Masley C, Boileau JF, Gelmon K. HER Story 鈥� The Next Chapter in HER2-Directed Therapy for Advanced Breast Cancer., Oncologist. 2013;18(11):1153-66.
  • Boileau JF, Easson A, Escallon JM, Leong WL, Reedijk M, Youngson BJ, McCready DR. Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed. Ann Surg Oncol. 2008 Jun;15(6):1710-6. Principal Author.

Follow us on:

Back to top